The Australian: ASX biotech September winners: Healthcare down 5pc, but experts say it’s still best sector in a recession

Arovella Therapeutics Ltd is pleased to be listed as one of the “ASX biotech winners for September”.

View full article

Previous
Previous

Arovella licenses novel solid tumour targeting technology

Next
Next

Arovella presents at TechKnow Invest Roadshow